Hepatitis A-typhoid vaccine (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis A-typhoid vaccine (GlaxoSmithKline)
Drug Alias NameHepatyrix
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis ATyphoid Fever
Global Approved IndicationsHepatitis ATyphoid Fever
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1999/06/01
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsHepatitis ATyphoid Fever
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA10
Related LinksWikipedia